Dorzolamide eye drops are manufactured by several pharmaceutical companies. The original innovator product was developed by Merck & Co. and marketed as Trusopt [1].
Who else makes dorzolamide eye drops?
Following the expiration of initial patents, generic versions of dorzolamide hydrochloride ophthalmic solution have become available from various manufacturers. These companies include Teva Pharmaceuticals, Akorn Pharmaceuticals, and Sun Pharmaceutical Industries, among others [2][3].
When did dorzolamide patents expire?
Patent expiration timelines can be complex and vary by country and specific patent. DrugPatentWatch.com tracks these patent statuses. Information on the specific patents and their expiration dates for dorzolamide can be found on their platform [4]. Generally, the patent protection for branded drugs like Trusopt would have expired, allowing for the introduction of generic competitors.
What are the different brand names for dorzolamide?
The primary brand name for dorzolamide eye drops in the United States is Trusopt [1]. Generic versions are typically labeled as "Dorzolamide Hydrochloride Ophthalmic Solution" [2][3].
How does dorzolamide work?
Dorzolamide is a carbonic anhydrase inhibitor [1]. It works by decreasing the production of aqueous humor in the eye, which helps to lower intraocular pressure [5]. This mechanism is crucial for managing conditions like glaucoma.